The outcome parameters in studies on patients with T2D and NPs were more consistent, and they included fasting blood glucose, glycated hemoglobin (HbA1c), fasting insulin, IR and β-cell function, lipid profile, BMI, C-reactive protein and adiponectin levels, the function of liver enzymes (AST, ALT), antioxidant capacity and the levels of pro-inflammatory cytokines, measured in two studies [72,74]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.